New study aims to uncover why pilonidal sinus wounds fail to heal

NCT ID NCT07370714

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 250 adults undergoing routine surgery for pilonidal sinus disease to understand why some wounds reopen. Researchers will track the sinus's distance from the anus, the disease stage, and the surgical method used. The goal is to identify factors that lead to wound dehiscence and slow healing, helping doctors improve surgical outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help surgeons choose techniques and identify patients at higher risk for wound problems, leading to better recovery.

What could go wrong

This is an observational study, not a treatment test. It will not prove what works best, only suggest possible links. Results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PILONIDAL SINUS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pilonidal sinus Surgical Wound Dehiscence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ankara Etlik City Hospital

    RECRUITING

    Ankara, Ankara, 06230, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••